FDA Drug Application (020823) for EXELON by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number020823
Product Number003
FormCAPSULE;ORAL
DosageEQ 1.5MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameEXELON
Active IngredientRIVASTIGMINE TARTRATE

Active IngredientCount
List of drugs with Active Ingredient RIVASTIGMINE2
List of drugs with Active Ingredient RIVASTIGMINE TARTRATE3


Back to FDA Applications sponsored by NOVARTIS